For the quarter ending 2025-12-27, TRNS had -$1,611K decrease in cash & cash equivalents over the period. $9,466K in free cash flow.
| Cash Flow | 2025-12-27 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|
| Net income | -1,101 | 1,269 | 3,261 |
| Net loss (gain) on disposal of property and equipment | 45 | -23 | -54 |
| Noncash lease expense | 1,152 | 1,119 | 915 |
| Deferred income taxes | 11 | -13 | 24 |
| Depreciation and amortization | 7,130 | 6,487 | 5,605 |
| Amortization of deferred financing costs | 39 | 26 | - |
| Gain on sale of assets | 0 | - | - |
| Provision for accounts receivable and inventory reserves | 135 | 140 | 118 |
| Stock-based compensation expense | 2,060 | 1,840 | 1,130 |
| Accounts receivable and other receivables | -3,674 | 2,336 | 1,214 |
| Inventory | 1,049 | -2,543 | 745 |
| Prepaid expenses and other current assets | -160 | 698 | -1,737 |
| Accounts payable | 2,094 | 1,727 | -3,300 |
| Accrued compensation and other current liabilities | 1,221 | 581 | -4,338 |
| Lease liabilities | -2,787 | - | - |
| Income taxes payable | -549 | 173 | 376 |
| Net cash provided by operating activities | 12,145 | 12,881 | 3,623 |
| Purchase of property and equipment | 2,679 | 4,432 | 4,598 |
| Business acquisitions, net of cash acquired | -1 | 82,526 | 0 |
| Proceeds from sale of assets | 0 | - | - |
| Sales of marketable securities | 0 | 0 | 0 |
| Net cash used in investing activities | -2,677 | -86,958 | -4,598 |
| Repayments of term loan | - | - | 602 |
| Proceeds from revolving credit facility, net of lender fees | -405 | 128,745 | 2,291 |
| Repayment of revolving credit facility | 11,999 | 50,042 | - |
| Repayments of term loan-Term Loan | 0 | 1,816 | - |
| Payments of deferred financing costs | -1 | 366 | - |
| Issuance of common stock, net of direct costs | 186 | 234 | 257 |
| Repurchase of common stock | -13 | 110 | 0 |
| Net cash provided by financing activities | -12,205 | 77,248 | 1,946 |
| Effect of exchange rate changes on cash and cash equivalents | 1,126 | 51 | -627 |
| Net increase (decrease) in cash and cash equivalents | -1,611 | 3,221 | 344 |
| Cash and cash equivalents at beginning of period | 5,082 | 1,517 | - |
| Cash and cash equivalents at end of period | 3,471 | 5,082 | - |
TRANSCAT INC (TRNS)
TRANSCAT INC (TRNS)